About this item
- Issue date:
- 23 September 2024
- Status:
- Current
- Corporate Author:
- Health New Zealand | Te Whatu Ora,
- Type:
- Research,
- Topic:
- COVID-19, Immunisation,
- Copyright status:
© Crown Copyright, Attribution 4.0 International (CC BY 4.0)
A study was conducted to explore individuals’ experiences by surveying people diagnosed with myocarditis and/or pericarditis following vaccination with Comirnaty. The study was not designed to confirm or investigate whether the vaccination event was the cause or related to the myocarditis or pericarditis. This report describes how the study was conducted and the results from the participant surveys.
Download: Report - DOCX, 781 KB
Long-term outcomes of myocarditis and pericarditis following vaccination with Comirnaty (Pfizer/BioNTech COVID-19 vaccine)
Download: Report - PDF, 996 KB
Long-term outcomes of myocarditis and pericarditis following vaccination with Comirnaty (Pfizer/BioNTech COVID-19 vaccine)
Download: Summary - PDF, 339 KB
Long-term outcomes of myocarditis and pericarditis following vaccination with Comirnaty (Pfizer/BioNTech COVID-19 vaccine)
Download: Summary - DOCX, 987 KB
Long-term outcomes of myocarditis and pericarditis following vaccination with Comirnaty (Pfizer/BioNTech COVID-19 vaccine)